Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment…per single pill.
That's exactly what happened in 2015 when Martin Shkreli, a hedge fund manager turned pharmaceutical executive, decided to hike the price of Daraprim, a drug used to treat toxoplasmosis. Overnight, a 5,456% increase made him the face of greed in medicine. The internet quickly gave him a nickname he'll never shake: "Pharma Bro."
